You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
8 September 2021
Perrigo is acquiring French consumer healthcare company HRA Pharma from Astorg and Goldman Sachs Asset Management for EUR1.8 billion (USD2.1 billion) in cash.
9 July 2021
The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has given the go-ahead for two oral contraceptive pills – HRA Pharma’s Hana and Maxwellia’s Lovima – to be sold without a prescription. Michelle Riddalls – chief executive officer of the Proprietary Association of Great Britain (PAG...
25 February 2021
HRA Pharma picks up the OTCToolbox Consumer Healthcare Industry (CHi) Award for Regulatory Achievement of the Year for a “milestone achievement” with its ellaOne brand in Italy.
15 February 2021
Two applications to switch oral contraceptives from prescription-only to pharmacy (POM to P) status in the UK are now out for consultation. If they are approved, then Maxwellia’s Lovima and HRA Pharma’s Hana will become the country’s first OTC oral contraceptive pills.
15 December 2020
French consumer healthcare company HRA Pharma is keen to acquire further “quality” brands and is open to exploring partnerships with distributors in Latin America and South-East Asia, says chief global commercial officer Martyn Hilton.
13 November 2020
HRA Pharma has appointed OTC Medical as exclusive distributor for its ellaOne, NorLevo and Compeed brands in the Netherlands with effect from January 2021.
15 October 2020
HRA Pharma’s ellaOne brand has become the first emergency contraceptive pill in Italy to be made available without a prescription to women under 18 years of age. David Wright, HRA Pharma’s chief executive officer, described the development as a “milestone achievement”.
12 March 2020
Acquiring the Mederma skincare brand helped HRA Pharma increase its worldwide sales by 21% to EUR254 million (USD279 million) in 2019.